Semaglutide cuts obesity, improves Heart Failure symptoms in Atrial Fibrillation: JACC Dr.Niharika Harsha B22 Oct 2024 9:00 AM ISTA recent secondary analysis from the pooled data of the STEP-HFpEF (Heart Failure with Preserved Ejection Fraction) Program and STEP-HFpEF DM found...
Novel procedure ReCET combined with semaglutide eliminates insulin dependence in type 2 diabetes: Study Dr. Kamal Kant Kohli15 Oct 2024 9:30 AM ISTGroundbreaking research presented today at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly...
Popular weight-loss drugs prove more costly than metabolic and bariatric surgery within one year unravels analysis Dr. Kamal Kant Kohli9 Oct 2024 8:00 PM ISTResearchers from USF Health Morsani College of Medicine in Tampa, FL compared the cumulative cost of pharmacotherapy with GLP-1 agonists to onetime...
Natco Pharma partner Mylan settles patent litigation with Novo Nordisk over generic Ozempic in US Ruchika Sharma7 Oct 2024 12:30 PM ISTHyderabad: NATCO Pharma Limited has announced that its partner Mylan Pharmaceuticals Inc. and Novo Nordisk have reached a settlement of the U.S....
Semaglutide effective as add on therapy for patients with hypertension and obesity, finds research Dr. Prem Aggarwal7 Oct 2024 9:00 AM ISTA new study published in the European Heart Journal showed that semaglutide is a helpful additional medication for the individuals who are obese and...
Present difference of approved and proposed formulation: CDSCO tells Novo Nordisk's Semaglutide tablet Dr. Divya Colin27 Sept 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major Novo Nordisk to import and market the antidiabetic drug Semaglutide tablets 1.5 mg,...
Semaglutide associated with lower opioid overdoses in people OUD and type 2 diabetes: JAMA Dr. Kamal Kant Kohli27 Sept 2024 9:00 AM ISTSince being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the...
Year-Long Weight Reduction with Semaglutide and Liraglutide: Study Reveals Impact of Dosage and Adherence Medha Baranwal16 Sept 2024 9:00 AM ISTUSA: The findings from a recent retrospective cohort study involving 3,389 patients with obesity revealed the effectiveness of semaglutide and...
Semaglutide and tirzepatide lead to better blood sugar control and weight loss in individuals with type 1 diabetes, finds study Dr. Kamal Kant Kohli16 Sept 2024 8:45 AM ISTSemaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who...
Semaglutide improves heart health outcomes beyond weight loss: ESC 2024 Dr. Kamal Kant Kohli12 Sept 2024 8:15 PM ISTSemaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss,...
Semaglutide taken for weight management does not increase risk of depression in people without known major psychopathology: JAMA Dr. Kamal Kant Kohli6 Sept 2024 8:00 AM ISTTaking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
Weight loss drug semaglutide reduced COVID-19 related deaths during pandemic, finds study Dr. Kamal Kant Kohli4 Sept 2024 6:15 AM ISTPatients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an...
